SAMANTHA AULT: Open Payments
NPI 1831512896 · ZANESVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$982 in 52 payments from 12 companies in 2025. Trend: 2023 $3,000 · 2024 $629 · 2025 $982
Food & beverage: $982
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 9 | $215 |
| Otsuka America Pharmaceutical, Inc. | 11 | $174 |
| Axsome Therapeutics, Inc. | 10 | $159 |
| E.R. Squibb & Sons, L.L.C. | 5 | $103 |
| Neurocrine BioSciences, Inc. | 5 | $93 |
| Supernus Pharmaceuticals, Inc. | 4 | $78 |
| Teva Pharmaceuticals USA, Inc. | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Janssen Pharmaceuticals, Inc | 1 | $28 |
| Lundbeck LLC | 1 | $26 |
Products named: Auvelity, ARISTADA, REXULTI, COBENFY, INGREZZA, LYBALVI, Qelbree, ABILIFY MAINTENA.
Industry payments across OH — which companies pay providers there.
